GlassScriptPhysician profile
Maohao Han
NPI 1467480145
$16,761.07
in general payments reported to CMS, 2019-2025
38 companies · $1,768 in 2025
The $1,768 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $245 · 2021: $727 · 2022: $665 · 2023: $12K · 2024: $1,130 · 2025: $1,768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Food and Beverage: $3,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $11,000.00 |
| Food and Beverage | $3,659.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,248.57 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $1,420.30 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $910.82 | 2019-2025 | Xifaxan, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $507.27 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Smith+Nephew, INC. | $441.15 | 2019-2025 | Pico, Pico 14, Collagenase Santyl |
| Janssen Biotech, INC. | $214.06 | 2022-2025 | Tremfya, Stelara, Simponi Aria |
| Ardelyx, INC. | $211.93 | 2024-2025 | Ibsrela |
| Aimmune Therapeutics, INC. | $208.16 | 2024-2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $157.71 | 2021-2022 | |
| Vivus LLC | $155.38 | 2021-2025 | Pancreaze |
| Madrigal Pharmaceuticals | $147.25 | 2025 | Rezdiffra |
| Gilead Sciences, INC. | $137.51 | 2025 | Livdelzi |
| Qol Medical, LLC | $127.87 | 2023-2024 | Sucraid, Sucraid |
| Phathom Pharmaceuticals, INC. | $124.01 | 2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $96.93 | 2021-2024 | Linzess |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evoke Pharma, INC. | $78.08 | 2022-2024 | Gimoti |
| Organon LLC | $58.76 | 2023-2025 | Hadlima |
| Baxter Healthcare | $50.87 | 2025 | Perclot |
| Merck Sharp & Dohme LLC | $50.31 | 2020-2021 | |
| Celgene Corporation | $43.60 | 2022-2023 | Zeposia |
| Intercept Pharmaceuticals, INC. | $39.45 | 2023-2025 | Ocaliva |
| Davol INC. | $37.07 | 2019-2023 | Xenmatrix Ab Surgical Graft |
| Medtronic, INC. | $36.54 | 2023-2025 | Pillcam, Gi Genius |
| Ethicon US, LLC | $32.95 | 2020-2025 | Vistaseal, Ethicon |
| Daiichi Sankyo INC. | $24.95 | 2021 | |
| Novo Nordisk INC | $24.51 | 2025 | Wegovy |
| Medical Device Business Services, INC. | $20.68 | 2019 | |
| Innovation Technologies INC | $17.78 | 2025 | Irrisept |
| Ipsen Biopharmaceuticals, INC | $17.58 | 2024 | Iqirvo |
| Shire North American Group INC | $17.35 | 2019 | |
| Applied Medical Technology INC | $15.96 | 2023 | Amt Capsule Monarch G-Tube, Traditional G-Jet, Amt Balloon G-Tube |
| Kci USA, INC. | $15.47 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.31 | 2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $13.41 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $12.81 | 2023 | Dupixent |
| Ucb, INC. | $12.11 | 2019 | |
| Medela LLC | $9.56 | 2020 | |
| Thd America, INC. | $7.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maohao Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.